[1]LEMON S M.Type A viral hepatitis:epidemiology,diagnosis,and prevention[J].Clini Chemi,1997,43(8Pt2) :1494-1499. [2]LIAW Y F,YANG C Y,CHU C M,et al.Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak[J].Infection,1986,14(4):156-158. [3]STAPLETON J T.Host immune response to hepatitis A virus[J].J infect Dis,1995,171(suppl 1):S9-14. [4]LU J,ZHOU Y,LIN X,et al.General epidemiological parameters of viral hepatitis A,B,C,and E in six regions of China:across-sectional study in 2007 [J].PLoS One,2009,4(12): e8467. [5]戴志澄,祁国明.中国病毒性肝炎血清流行病学调查:上卷[M].北京:北京科技出版社,1997:21-38. [6]周莉薇,杨媛媛,马学,等.宁夏健康人群甲型病毒性肝炎抗体水平调查[J].宁夏医学杂志,2012,34(7):628-629. [7]路滟,廖玉学,董书贤,等.深圳市甲型病毒性肝炎血清流行病学调查[J].中华疾病控制杂志,2015,19(6):632-634. [8]秦莎莎,廖贵蓉,裴小琴,等.我国甲肝免疫状况分析—基于多水平 Meta 分析结果[J].现代预防医学,2010,37(6):1021-1022. [9]丁春喜.嘉善县人群甲型肝炎免疫水平监测[J].浙江预防医学,2011, 23(7):33-34. [10]曾永,项晓青,陈明,等.青田县 2007 年人群甲型肝炎血清流行病学调查[J].浙江预防医学,2009,21(8):19-21. [11]李奕新,田建三,鲍庆汉,等.淳安人群甲型肝炎抗体水平调查分析[J].浙江预防医学,2007,19(2):23-24. [12]彭文伟.传染病学[M].6版.北京:人民卫生出版社,2004:21-50.